3//SEC Filing
DRW Holdings, LLC 3
Accession 0001193805-21-001122
CIK 0000882361other
Filed
Aug 4, 8:00 PM ET
Accepted
Aug 5, 9:53 PM ET
Size
13.5 KB
Accession
0001193805-21-001122
Insider Transaction Report
Form 3
DRW Commodities, LLC
10% Owner
Holdings
- 4,162(indirect: By LLC)
Common Stock
- 8,891,076(indirect: By LLC)
Common Stock
Wilson Donald R. Jr.
10% Owner
Holdings
- 4,162(indirect: By LLC)
Common Stock
- 8,891,076(indirect: By LLC)
Common Stock
DRW Holdings, LLC
10% Owner
Holdings
- 4,162(indirect: By LLC)
Common Stock
- 8,891,076(indirect: By LLC)
Common Stock
Footnotes (2)
- [F1]This Form 3 is being filed by the undersigned Donald R. Wilson Jr. ("Wilson"), as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the "Reporting Persons"). Wilson is the sole manager of each of DRW Investments, LLC ("DRW Investments"), DRW Commodities, LLC ("DRW Commodities") and DRW Holdings, LLC ("DRW Holdings"). DRW Holdings owns 100% of the outstanding equity of each of DRW Commodities and DRW Investments. A majority of the equity of DRW Holdings is owned, directly or indirectly, by trusts for the benefit of members of Wilson's immediate family and of which Wilson serves as trustee or investment advisor.
- [F2]Each of the Reporting Persons disclaims beneficial ownership of any securities held by DRW Commodities or DRW Investments, except to the extent of its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise.
Documents
Issuer
Aptose Biosciences Inc.
CIK 0000882361
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001535383
Filing Metadata
- Form type
- 3
- Filed
- Aug 4, 8:00 PM ET
- Accepted
- Aug 5, 9:53 PM ET
- Size
- 13.5 KB